A specific gut microbiota pattern was found to predict new cardiovascular events in patients with coronary heart disease, ...

Circulating ceramides have recently emerged as an independent risk factor for atherosclerotic cardiovascular disease, but precisely how they contribute to the pathogenesis of atherosclerosis ...

The understanding of the pathophysiology of atherosclerosis and related vascular diseases has changed over the last decade, providing new perspectives for preventive and therapeutic strategies.

Deciphering the gut biome's, including helminths', influence on human trained immunity will unlock novel immunotherapies harnessing the immune reprogramming potential of their secreted factors and ...

The distinction between biological and chronological age is vital for risk assessment and interventions aimed at enhancing longevity and quality of life.

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

a process that is central to the pathogenesis of atherosclerosis. In ART-naive patients, the proinflammatory state may contribute to mortality including CVD. Assessment & Management of CVD Risk in ...

India has a high prediabetes prevalence (15.3%), nearly equal in urban (15.4%) and rural (15.2%) areas. (1) In India, ...

Atherosclerosis Inflammation Program Veru has evolved its ... cholesterol jointly contribute to atherosclerotic cardiovascular disease. It appears that the pathogenesis and progression of coronary ...

THE role of lipids as predictors of coronary heart disease has become of considerable interest during the past two decades. Many individual lipids, such as the serum cholesterol, phospholipid and ...

Ultimately, these effects of ImP accelerate the progression of atherosclerosis, thereby linking it to the pathophysiology of ACVD (Graphic Abstract). Our studies indicate that ImP exerts deleterious ...